Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ENSC — Ensysce Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to ENSC Full portfolio

Position in ENSC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,941
-$3,295 QoQ
Shares Held
34,280
+34879.6% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 17 holders
Holding Since
Mar 2022
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENSC Over Time

Shares Held

Position Value (USD)

Derivatives in ENSC

reported options exposure · as of Jun 30, 2022
CallValue
$59,631
CallShares
19
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. ENSC ranks #322 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in ENSC

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,941 34,280
2022-12-31 $13,236 17,649
2022-06-30 $59,631 68,700
2022-06-30 $13,361 15,393
2022-03-31 $102,258 89,700